Cover Image
市场调查报告书

眼炎:全球临床实验趋势

Ocular Inflammation Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品编码 338377
出版日期 内容信息 英文 251 Pages
订单完成后即时交付
价格
Back to Top
眼炎:全球临床实验趋势 Ocular Inflammation Global Clinical Trials Review, H2, 2016
出版日期: 2016年12月21日 内容信息: 英文 251 Pages
简介

本报告提供眼炎临床实验最新趋势相关分析,提供您各地区的临床实验数量,临床实验的各阶段进展,实验对象采用状况,汇整有潜力的赞助商,各企业和研究机关的研究进展,有潜力的药剂比较等信息。

简介

  • 眼炎
  • 本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5国的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲的主要5个国家临床实验数量
    • 中南美的主要5个国家临床实验数量

G7各国临床实验数量:眼科疾病治疗药临床实验上眼炎的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:眼科疾病治疗药临床实验上眼炎的比例

E7各国的各阶段临床实验数量

E7各国临床实验数量:各进展状况

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

未完成的临床实验数量

一定期间所采用的实验对象

赞助商类别的临床实验数量

有潜力的赞助商

眼炎治疗药临床实验的主要参与企业

有潜力的药剂

最新临床实验新闻

临床实验简介

  • 主要企业临床实验概要
    • Novartis AG
    • Valeant Pharmaceuticals International, Inc.
    • XOMA Corporation
    • Alcon, Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Sirion Therapeutics, Inc. (Inactive)
    • Allergan Plc
    • SIFI S.p.A
    • Celgene Corporation
  • 有代表性的研究机关·医院临床实验概要
    • National Eye Institute
    • Oregon Health & Science University
    • Medical University of Vienna
    • Moorfields Eye Hospital NHS Foundation Trust
    • The Johns Hopkins University
    • University of California, San Francisco
    • Capital Medical University
    • Duke University
    • Erasmus MC
    • Isfahan University of Medical Sciences

5个有代表性的临床实验简介

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC4013CTIDB

GlobalData's clinical trial report, "Ocular Inflammation Global Clinical Trials Review, H2, 2016" provides an overview of Ocular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ocular Inflammation Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Ocular Inflammation
      • Dec 05, 2016: Noveome Initiates Phase 2 Clinical Trial of ST266 for the Treatment of Allergic Conjunctivitis
      • Nov 14, 2016: Ocular Therapeutix Announces Successful Topline Results for Both Inflammation and Pain Primary Efficacy Endpoints from Phase 3 Clinical Trial of DEXTENZA
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2016*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2016*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top